BIOMAT Database Logo BIOMAT Database Logo

Recombinant human erythropoietin for anaemia associated with chronic renal failure in predialysis patients. 1992

R M Schaefer, and L Schaefer, and A Heidland
Department of Nephrology, University of Wuerzburg, Germany.

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004920 Erythropoiesis The production of red blood cells (ERYTHROCYTES). In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction. Erythropoieses
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D006400 Hematocrit The volume of packed RED BLOOD CELLS in a blood specimen. The volume is measured by centrifugation in a tube with graduated markings, or with automated blood cell counters. It is an indicator of erythrocyte status in disease. For example, ANEMIA shows a low value; POLYCYTHEMIA, a high value. Erythrocyte Volume, Packed,Packed Red-Cell Volume,Erythrocyte Volumes, Packed,Hematocrits,Packed Erythrocyte Volume,Packed Erythrocyte Volumes,Packed Red Cell Volume,Packed Red-Cell Volumes,Red-Cell Volume, Packed,Red-Cell Volumes, Packed,Volume, Packed Erythrocyte,Volume, Packed Red-Cell,Volumes, Packed Erythrocyte,Volumes, Packed Red-Cell

Related Publications

R M Schaefer, and L Schaefer, and A Heidland
[Anaemia treatment with recombinant human erythropoietin in predialysis patients with chronic renal failure--own experience].
October 2003, Polskie Archiwum Medycyny Wewnetrznej,
R M Schaefer, and L Schaefer, and A Heidland
Study of the effect of recombinant erythropoietin on renal anaemia in predialysis patients with chronic renal failure.
January 1994, Folia medica,
R M Schaefer, and L Schaefer, and A Heidland
Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.
November 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation,
R M Schaefer, and L Schaefer, and A Heidland
Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
January 2001, The Cochrane database of systematic reviews,
R M Schaefer, and L Schaefer, and A Heidland
Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
July 2005, The Cochrane database of systematic reviews,
R M Schaefer, and L Schaefer, and A Heidland
Effects of human recombinant erythropoietin on anaemia, systemic haemodynamics and renal function in predialysis renal failure patients.
January 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
R M Schaefer, and L Schaefer, and A Heidland
Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. The US Recombinant Human Erythropoietin Predialysis Study Group.
July 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation,
R M Schaefer, and L Schaefer, and A Heidland
Treatment of the anaemia of chronic renal failure with recombinant human erythropoietin.
September 1989, Drugs,
R M Schaefer, and L Schaefer, and A Heidland
Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients.
April 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation,
R M Schaefer, and L Schaefer, and A Heidland
[The effect of low doses of recombinant human erythropoietin on renal anemia in predialysis patients with chronic renal failure].
July 1993, Zhonghua nei ke za zhi,
Copied contents to your clipboard!